Keyword Analysis & Research: biomarin


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
biomarin0.090.76813428

Keyword Research: People who searched biomarin also searched

Keyword CPC PCC Volume Score
biomarin0.570.3753673
biomarin stock0.170.8762955
biomarin pharmaceutical1.110.7997829
biomarin careers0.70.8275822
biomarin stock price0.870.3368769
biomarin pipeline1.580.9724342
biomarin logo0.160.7637551
biomarin news1.080.5814983
biomarin san rafael1.770.1893731
biomarin official site1.840.6454152
biomarin cork0.880.9529814
biomarine medical1.090.7849036
biomarine 11400.190.6731197
biomarin share price1.380.8578148
biomarin aktie1.040.5917071
biomarin aktienkurs1.840.8293599
biomarin pharmaceutical stock1.460.2113059
biomarin international limited1.02161156
biomarine medical immuno neuro lipids0.740.591686

Search Results related to biomarin on Search Engine

  • BioMarin Pharmaceutical Inc.

    biomarin.com

    https://www.biomarin.com/

    WEBApr 2, 2024 · BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.

    DA: 60 PA: 18 MOZ Rank: 33

  • About Us | BioMarin

    biomarin.com

    https://www.biomarin.com/company/

    WEBBioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Our Purpose.

    DA: 91 PA: 10 MOZ Rank: 48

  • Our Science | BioMarin

    biomarin.com

    https://www.biomarin.com/science/

    WEBAt BioMarin, we’re committed to delivering on the promise of genetic discoveries by translating them into transformative medicines. To achieve this, we: Leverage genetic discoveries and tools to ensure a clear understanding of the …

    DA: 80 PA: 74 MOZ Rank: 7

  • BioMarin Pharmaceutical - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/BioMarin_Pharmaceutical

    WEBBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research …

    DA: 97 PA: 43 MOZ Rank: 81

  • Pipeline | BioMarin

    biomarin.com

    https://www.biomarin.com/products-and-pipeline/research-pipeline/

    WEBMar 13, 2024 · Our robust pipeline includes investigational medicines across four areas of focus. We pursue innovative therapies that address unmet medical needs, guided by a fundamental understanding of the genetics and underlying biology of the conditions we seek to help treat. Updated March 13, 2024.

    DA: 29 PA: 20 MOZ Rank: 84

  • Products and Pipeline | BioMarin

    biomarin.com

    https://www.biomarin.com/products-and-pipeline/

    WEBWe leverage expertise in genetics and genomics to create new medicines for people with serious medical conditions. Learn more about our products and pipeline.

    DA: 49 PA: 30 MOZ Rank: 49

  • Products | BioMarin

    biomarin.com

    https://www.biomarin.com/products-and-pipeline/products/

    WEBWe provide eight important treatment options for people living with serious medical conditions. Learn more about our marketed products below. Note: The product information provided below is intended for U.S. audiences only. Central Nervous System. Musculoskeletal/Metabolic. Non-Oncology Hematology. Aldurazyme ®. laronidase.

    DA: 55 PA: 38 MOZ Rank: 63

  • BioMarin Pharmaceutical Inc. - BioMarin Reports Record …

    biomarin.com

    https://investors.biomarin.com/news/news-details/2024/BioMarin-Reports-Record-Financial-Results-for-the-Fourth-Quarter-and-Full-year-2023-and-Provides-Financial-Guidance-for-2024/default.aspx

    WEBFeb 22, 2024 · BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024. February 22, 2024. Total FY'23 Revenues of $2.42 Billion (+15% Y/Y and +20% Y/Y at Constant Currency); GAAP Diluted Earnings per Share of $0.87 (+16% Y/Y) and Non-GAAP Diluted Earnings per Share of …

    DA: 48 PA: 78 MOZ Rank: 23

  • US FDA approves BioMarin's gene therapy for hemophilia A

    reuters.com

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-biomarins-gene-therapy-hemophilia-2023-06-29/

    WEBJune 29 (Reuters) - The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's (BMRN.O) gene therapy for severe hemophilia A, the company said, giving patients with the...

    DA: 78 PA: 7 MOZ Rank: 38

  • BioMarin Pharmaceutical Inc. - U.S. Food and Drug …

    biomarin.com

    https://investors.biomarin.com/news/news-details/2023/U.S.-Food-and-Drug-Administration-Approves-BioMarins-VOXZOGO-vosoritide-for-Children-Under-5-Years-with-Achondroplasia-10-20-2023/default.aspx

    WEBSAN RAFAEL, Calif., Oct. 20, 2023 / PRNewswire / -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VOXZOGO ® (vosoritide) …

    DA: 42 PA: 58 MOZ Rank: 86